GridAI Technologies (GRDX) Total Current Liabilities (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Total Current Liabilities came in at $14.1 million in Q2 2026, down 52.33% on a YoY basis from $29.7 million in Q2 2025, and down 6.69% quarter-over-quarter from $15.2 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Total Current Liabilities (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Total Current Liabilities for 12 consecutive years, with $14.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities fell 52.33% year-over-year to $14.1 million; the trailing twelve-month figure through Jun 2026 stood at $14.1 million (down 52.33% YoY), and the FY2025 full-year result was $15.2 million, down 44.97% from the prior year.
- Total Current Liabilities declined to $14.1 million in Q2 2026 per GRDX's latest filing, from $15.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $33.5 million in Q3 2025 and bottomed at $2.5 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $14.0 million across 5 years, with a median of $14.2 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities tumbled 81.54% in 2023, then soared 779.14% in 2024.
- Over 5 years, Total Current Liabilities stood at $2.5 million in 2022, then climbed by 26.17% to $3.1 million in 2023, then surged by 779.14% to $27.5 million in 2024, then plunged by 44.97% to $15.2 million in 2025, then retreated by 6.69% to $14.1 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $14.1 million, $15.2 million, and $33.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.58 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 2.53 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 283.60 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 14.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.15 Mn |
| Dec 31, 2025 | 15.16 Mn |
| Sep 30, 2025 | 33.52 Mn |
| Jun 30, 2025 | 29.68 Mn |
| Mar 31, 2025 | 28.74 Mn |
| Dec 31, 2024 | 27.55 Mn |
| Sep 30, 2024 | 15.69 Mn |
| Jun 30, 2024 | 15.38 Mn |
| Mar 31, 2024 | 6.17 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 6.69 Mn |
| Jun 30, 2022 | 17.28 Mn |
| Mar 31, 2022 | 14.22 Mn |
| Dec 31, 2021 | 12.30 Mn |
| Sep 30, 2021 | 19.10 Mn |
| Jun 30, 2021 | 6.45 Mn |